RxNorm Semantic Concepts Index - 183
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "183".
| Concept ID (RxCUI) | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| Concept ID (RxCUI): 18308 | Arogenate dehydrogenase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 18308 | Arogenate dehydrogenase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 18308 | Arogenate dehydrogenase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 18308 | Arogenate dehydrogenase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 183080 | Bacterial luciferase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 183080 | Bacterial luciferase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 183080 | Bacterial luciferase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 183080 | Bacterial luciferase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 18311 | Aromatic amine dehydrogenase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 18311 | Aromatic amine dehydrogenase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 18311 | Aromatic amine dehydrogenase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 18312 | Aromatic-amino-acid aminotransferase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 18312 | Aromatic-amino-acid aminotransferase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 18314 | Aromatic-amino-acid-glyoxylate aminotransferase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 18314 | Aromatic-amino-acid-glyoxylate aminotransferase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 18330 | White arsenic | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 18330 | White arsenic | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 18330 | White arsenic | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 18330 | White arsenic | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 18330 | White arsenic | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 18330 | White arsenic | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 18330 | White arsenic | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 183379 | rivastigmine | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 183379 | rivastigmine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 183379 | rivastigmine | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 183379 | rivastigmine | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 183379 | rivastigmine | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 18343 | artemether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 18343 | artemether | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 18343 | artemether | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 18343 | artemether | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 18343 | artemether | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 18346 | artesunate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 18346 | artesunate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 18346 | artesunate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 18346 | artesunate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 18346 | artesunate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 1834833 | Bovine plasmin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 18352 | Aryl acylamidase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 18352 | Aryl acylamidase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 18354 | Aryl-alcohol dehydrogenase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 18354 | Aryl-alcohol dehydrogenase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 18360 | Aromatic esterase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 18360 | Aromatic esterase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 18360 | Aromatic esterase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 18361 | Arylamine N-acetyltransferase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 18361 | Arylamine N-acetyltransferase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 18361 | Arylamine N-acetyltransferase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 18361 | Arylamine N-acetyltransferase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 18365 | Steroid sulfatase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 18365 | Steroid sulfatase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 18365 | Steroid sulfatase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 18365 | Steroid sulfatase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1837 | Butaperazine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1837 | Butaperazine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 1837326 | Interleukin 2 receptor alpha chain soluble | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 1837326 | Interleukin 2 receptor alpha chain soluble | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 18376 | Asclepain | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 18376 | Asclepain | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 183830 | iocetamic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 18385 | Ascriptin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 183875 | fominoben | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 183877 | clofezone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 183883 | Normethandrone | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 183883 | Normethandrone | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 183883 | Normethandrone | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 183888 | Tritec | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |